Clinical Trials on End-Stage Renal Disease in Argentina

Total 3537 results

ViiV Healthcare
GlaxoSmithKline

Completed

Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.

Infection, Human Immunodeficiency Virus

Argentina
Overture Life

Recruiting

DaVitri: Semi-Automated Vitrificacion Clinical Study (DaVitri)

Fertility Issues

Argentina
Hospital Italiano de Buenos Aires
Sociedad Argentina de Hipertension Arterial (SAHA)

Completed

Polymorphisms of the Thiazide's Receptor Gene SLC12A3 and Development of Hyponatremia

Thiazide Diuretics Induced Hyponatremia

Argentina
Clínica Bazterrica

Withdrawn

Efficacy of a Web-based Lifestyle Modification Program in Obese Patients With Cardiovascular Risk Factors

Obesity

Argentina
The Foundation for Orthopaedics and Regenerative...

Recruiting

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCI

Spinal Cord Injuries

Argentina
Novartis

Completed

Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency

Diabetes Mellitus, Type 2

Spain, Argentina, Russian Federation, Norway, India, Sweden, Finland, France, Canada, Germany, Australia, Costa Rica
Universidad Nacional de Rosario

Completed

Alzheimer's Disease Reminiscence Quality of Life

Alzheimer's Disease

Argentina
Hospital Italiano de Buenos Aires

Completed

High Flow Nasal Cannula in Immediately Post Extubation (HFNC)

Airway Extubation | Oxygen Inhalation Therapy

Argentina
Mitsubishi Tanabe Pharma Corporation
Kureha Corporation

Completed

A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)

Chronic Kidney Disease

United States, France, Italy, Ukraine, Argentina, Mexico, Poland, Canada, Brazil, Russian Federation, Czechia, Puerto Rico
Hoffmann-La Roche

Completed

A Study of the Safety of Atezolizumab in Patients With Advanced or Metastatic Urothelial Carcinoma in Argentina

Urothelial Carcinoma

Argentina
Bio Sidus SA

Completed

PK/PD Study of 2 Agalsidase Formulations in Single Dose of 1 mg/kg Administered to Healthy Volunteers as IV Infusion

Fabry Disease

Argentina
AstraZeneca

Completed

To Assess Adherence to the Treatment and Quality of Life in Patients With Hypertension (ADHERENCE)

Hypertension

Argentina
Instituto Cardiovascular de Buenos Aires

Unknown

Use of a Smartphone Application to Increase Adherence to Medical Treatment in Patients With an Acute Coronary Syndrome. (ADHERENCE)

Adherence, Medication

Argentina
Bayer

Completed

Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs (START)

Pulmonary Arterial Hypertension

Argentina
Promedon

Active, not recruiting

New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis (PROMGEL-OA)

Pain | Osteoarthritis, Knee

Argentina
Hoffmann-La Roche

Completed

A Study of the Safety of Atezolizumab in Participants With Locally Advanced or Metastatic Non Small Cell Lung Cancer in Argentina

Carcinoma, Non-small-cell Lung

Argentina
Hospital General de Niños Pedro de Elizalde

Terminated

Two Bag System for Hydration in Diabetes

Diabetes | Ketoacidosis

Argentina
Hospital Italiano de Buenos Aires

Completed

Hemodynamic Changes of Patients Receiving Atenolol/Bisoprolol (CHAB)

Hypertension | Metabolic Syndrome

Argentina
Gema Biotech S.A.
QUID Quality in Drugs and Devices Latin American Consulting SRL

Unknown

Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 )

Rheumatoid Arthritis

Argentina
Gema Biotech S.A.
QUID Quality in Drugs and Devices Latin American Consulting SRL

Completed

Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis (GEMENE)

Rheumatoid Arthritis

Argentina
Cerus Endovascular, Ltd

Terminated

INCA: Intracranial Aneurysm Treatment With NeXsys (INCA)

Intracranial Aneurysm

Argentina
Hospital Nacional Profesor Alejandro Posadas

Completed

HYPONATREMIA IN COVID-19 PATIENTS

Covid19 | Corona Virus Infection | Hyponatremia

Argentina
Osmotica Pharmaceutical US LLC

Completed

Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease

Parkinson's Disease

Argentina
Laboratorio Elea Phoenix S.A.

Completed

Immunotherapy With Racotumomab Versus Support Treatment in Advanced Non-small Cell Lung Cancer Patients

Advanced Non-small Cell Lung Cancer

Argentina
Hospital Italiano de Buenos Aires
Boehringer Ingelheim

Unknown

Discontinuation for Oral Anticoagulants in Patients With Atrial Fibrillation

Anticoagulant Drugs | Auricular Fibrillation

Argentina
Drugs for Neglected Diseases
LAT Research

Completed

Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease (Pop PK Chagas)

Chagas' Disease

Argentina
Hospital Italiano de Buenos Aires

Unknown

High Flow Nasal Cannula and Aerobic Capacity Training

COPD

Argentina
Alcon Research

Completed

Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma

Glaucoma

Argentina
Hospital Italiano de Buenos Aires

Enrolling by invitation

Multicenter Validation Study of an Artificial Intelligence Tool for Automatic Classification of Chest X-rays

Pneumothorax | Pleural Effusion | Bone Fracture | Consolidation | Opacity

Argentina
AVEO Pharmaceuticals, Inc.

Completed

A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma (TIVO-1)

Advanced Renal Cell Carcinoma

United States, Argentina, Bulgaria, Canada, Chile, Czechia, France, Hungary, India, Italy, Poland, Romania, Russian Federation, Serbia, Ukraine, United Kingdom
Hospital Italiano de Buenos Aires

Completed

Institutional Registry of Hyponatremia (Hyponatremia)

Hyponatremia

Argentina
Hospital Italiano de Buenos Aires

Recruiting

Multiple Sclerosis Registry in Argentina (RelevarEM) (RelevarEM)

Multiple Sclerosis

Argentina
Hospital Italiano de Buenos Aires

Unknown

Real-world Data of Ocrelizumab in Multiple Sclerosis in LATAM (RWD_ocre)

Multiple Sclerosis

Argentina
Merck KGaA, Darmstadt, Germany
Merck Quimica Argentina S.A.I.C

Completed

Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)

Multiple Sclerosis, Relapsing Remitting

Argentina
Laboratorio Elea Phoenix S.A.
Ministerio de Ciencia e Innovación, Spain

Completed

Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

Glioma | Neuroblastoma | Retinoblastoma | Wilm's Tumor | Ewing's Sarcoma

Argentina
Merck KGaA, Darmstadt, Germany

Completed

Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in Argentina

Multiple Sclerosis

Argentina
Sociedad Argentina de Cardiología

Recruiting

LATIN SHOCK: Latin American Registry of Cardiogenic Shock in the Context of Acute Coronary Syndrome (LATIN-SHOCK)

Acute Coronary Syndrome | Cardiogenic Shock

Argentina
Laboratorio Elea Phoenix S.A.

Completed

Perioperative Use of Desmopressin (DDAVP) in Breast Cancer

Breast Cancer

Argentina
Hospital de Niños R. Gutierrez de Buenos Aires
The Hospital for Sick Children

Active, not recruiting

Treatment of Asymptomatic Toxocariasis With Albendazole in Children

Toxocariasis

Argentina
Hospital Italiano de Buenos Aires

Completed

Loco/Regional Anaesthesia Evaluation in Laparoscopic Hernioplasty

Postoperative Pain

Argentina
Pedro Cahn
Merck Sharp & Dohme LLC

Terminated

Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

HIV Infections

Argentina
Hospital Italiano de Buenos Aires

Active, not recruiting

BIS-Guided Sedation in Critically Ill Patients Under Deep Sedation

Delirium | Sedative Overdose

Argentina
Helios Salud
Abbott

Unknown

Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen

Dyslipidemia | HIV | Hypercholesterolemia

Argentina
Austral University, Argentina

Recruiting

Cardiometabolic Risk Factors Registry (CARFARE)

Cardiovascular Diseases | Obesity | Diabetes | Atherosclerosis | Metabolic Syndrome | Cardiovascular Risk Factor

Argentina
Grupo Argentino de Tratamiento de la Leucemia Aguda

Unknown

Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia

Leukemia

Argentina
University of Miami
National Institute of Mental Health (NIMH); Fundacion Huesped, Buenos Aires... and other collaborators

Completed

Positive Connections: COPA2

Human Immunodeficiency Virus

Argentina
Centro de Educación Medica e Investigaciones Clínicas...

Completed

Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia

Covid19 Pneumonia

Argentina
Sanatorio Finochietto

Completed

Tocilizumab in Covid-19 Penumonia in Buenos Aires City

COVID-19 Pneumonia | Tocilizumab

Argentina
Florida State University
Nexo Asociacion Civil

Recruiting

Electronic SBI(RT) for MSM in Argentina

HIV | Substance Abuse

Argentina
Helse Stavanger HF
Universidad Católica de Salta

Completed

ARgentinean Risk Assessment Registry in ACS; the ARRA-RACS Study (ARRA-RACS)

Myocardial Infarction | Coronary Artery Disease | Chest Pain | Unstable Angina Pectoris

Norway, Argentina

Clinical Trials on End-Stage Renal Disease in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations